Dopa-responsive dystonia
Kaakkola, S.; Iivanainen, M.
Duodecim; Laaketieteellinen Aikakauskirja 110(13): 1271-1274
1994
ISSN/ISBN: 0012-7183 PMID: 7497939 Document Number: 438538
Document emailed within 1 workday
Related Documents
Rondot, P.; Ziegler, M. 1983: Dystonia--L-dopa responsive or juvenile parkinsonism? Journal of Neural Transmission. Supplementum 19: 273-281Kamal, N.; Bhat, D.P.; Carrick, E. 2006: Dopa-responsive dystonia (Segawa syndrome) Indian Pediatrics 43(7): 635-638
Takahashi, H.; Snow, B.J.; Nygaard, T.G.; Calne, D.B. 1993: Clinical heterogeneity of dopa-responsive dystonia: PET observations Advances in Neurology 60: 586-590
Ichinose, H.; Suzuki, T.; Inagaki, H.; Ohye, T.; Nagatsu, T. 2001: DOPA-responsive dystonia. from causative gene to molecular mechanism Advances in Neurology 86: 173-176
Furukawa, Y. 2006: Dopa-responsive dystonia: clinical, genetic, and biochemical studies Rinsho Shinkeigaku 46(1): 19-34
Maruta, K.; Okamoto, S.; Takegami, T. 1993: A form of dopa-responsive dystonia of late onset with diurnal fluctuations Rinsho Shinkeigaku 33(3): 341-343
Furukawa, Y.; Shimadzu, M.; Hornykiewicz, O.; Kish, S.J. 1998: Molecular and biochemical aspects of hereditary progressive and dopa-responsive dystonia Advances in Neurology 78: 267-282
Yoshikawa, H.; Matsuo, T.; Sakuragawa, N. 1990: Effect of L-dopa in dystonia which was worsened by exercise and improved by resting; a care report No to Hattatsu 22(3): 290-292
Gherpelli, J.L.; Nagae, L.M.; Diament, A. 1995: DOPA-sensitive progressive dystonia of childhood with diurnal fluctuations of symptoms: a case report Arquivos de Neuro-Psiquiatria 53(2): 298-301
Marsden, C.D. 1976: The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis, or axial dystonia) Advances in Neurology 14: 259-276
Bergonzi, P.; Chiurulla, C.; Gambi, D.; Mennuni, G.; Pinto, F. 1975: L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment Acta Neurologica Belgica 75(1): 5-10
Bizzarri, B.Mattia.; Tortolini, S.; Rotelli, L.; Botta, G.; Saladino, R. 2015: Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity Current Medicinal Chemistry 22(36): 4138-4165
Hansson, C.; Rorsman, H.; Rosengren, E. 1981: Pronounced formation of 5-OH-dopa at enzymatic oxidation of DOPA in the presence of ascorbic acid Acta Dermato-Venereologica 61(2): 147-148
Riley, P.A. 1999: The great DOPA mystery: the source and significance of DOPA in phase i melanogenesis Cellular and Molecular Biology 45(7): 951-960
Guillard, A. 1972: Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor Bruxelles Medical 52(10): 673-680
Blair, M.L.; Reid, I.A.; Ganong, W.F. 1977: Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs Journal of Pharmacology and Experimental Therapeutics 202(1): 209-215
Routh, J.I.; Bannow, R.E.; Fincham, R.W.; Stoll, J.L. 1971: Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy Clinical Chemistry 17(9): 867-871
Zabel, M. 1979: Ultrastructure of thyroid C cells following long-term administration of 1-DOPA or alpha-methyl-DOPA Acta Medica Polona 20(1): 53-54
Vasil'ev, V.N. 1980: Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients Voprosy Meditsinskoi Khimii 26(6): 782-786
Gauthier, G.; de Ajuriaguerra, J.; Geissbuhler, F.; Simona, B.; Constantinidis, J.; Yanniotis, G.; Krassoievitch, M.; Eisenring, J.J.; Tissot, R. 1971: Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa? La Presse Medicale 79(3): 91-92